Company / Current Assets
Crinetics Pharmaceuticals, Inc. Current Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.0B
FY2025
5-year range
$344.7M / $1.4B
FY2021-FY2025
Trend
-23.8%
vs FY2024
Sector context
#45 of 213
Health Care
What the data says
Crinetics Pharmaceuticals, Inc.'s current assets of $1.0B is higher than 79% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 9 years, ranging from $15M in FY2017 to $1.4B in FY2024.
Based on SEC 10-K filings.
$1.0B in FY2025 with a 5-year CAGR of +42.6%. Top quartile in the Health Care sector.
Improved from $574M to $1.0B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +44.8%
- 5-Year CAGR
- +42.6%
- 10-Year CAGR
- -
Sector benchmark
-58.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +42.6%, indicating consistent growth.
- In FY2025, current assets decreased 23.8% year-over-year.
- Ranks #45 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | -23.8% |
| FY2024 | $1.4B | +139.6% |
| FY2023 | $574.2M | +66.3% |
| FY2022 | $345.2M | +0.1% |
| FY2021 | $344.7M | +94.2% |
| FY2020 | $177.5M | +43.9% |
| FY2019 | $123.3M | -26.0% |
| FY2018 | $166.7M | +999.1% |
| FY2017 | $15.2M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026